HBMBF (HBM Healthcare Investments) Research & Development: $0.0 Mil (TTM As of Mar. 2026)


HBMBF HBM Healthcare Investments Ltd HBMBF
24 GF Score
Price $287.35
! 6 Warning Signs
View Full Analysis

What is HBM Healthcare Investments Research & Development?

HBM Healthcare Investments HBMBF 24 Research & Development is $0.0 Mil as of Mar. 2026. GuruFocus rates HBMBF with a GF Score™ of 24/100. The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. HBM Healthcare Investments's Research & Development for the three months ended in Mar. 2026 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.0 Mil.

HBM Healthcare Investments  (OTCPK:HBMBF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

HBM Healthcare Investments Research & Development Related Terms

HBM Healthcare Investments Research & Development Historical Data

* Premium members only.

The historical data trend for HBM Healthcare Investments's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HBM Healthcare Investments Research & Development Chart

HBM Healthcare Investments Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

HBM Healthcare Investments Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HBMBF
24GF Score
HBM Healthcare Investments Ltd HBMBF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HBM Healthcare Investments Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
HBM Healthcare Investments (HBMBF) has a Research & Development of $0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on HBM Healthcare Investments and its competitors.
Is HBM Healthcare Investments' Research & Development too high?
HBM Healthcare Investments' current Research & Development is $0.0 Mil. Overall, HBM Healthcare Investments has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does HBM Healthcare Investments' Research & Development compare to BLK and BX?
HBM Healthcare Investments' Research & Development of $0.0 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on HBM Healthcare Investments and its competitors. HBM Healthcare Investments's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HBM Healthcare Investments stock overvalued right now?
HBM Healthcare Investments (HBMBF) has a current Research & Development of $0.0 Mil. The current Research & Development is $0.0 Mil. HBM Healthcare Investments' overall GF Score™ is 24/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For HBM Healthcare Investments (HBMBF), the current Research & Development is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HBM Healthcare Investments Business Description

Address Bundesplatz 1, Zug, CHE, 6300
HBM Healthcare Investments Ltd is a Switzerland-based holding company. The firm actively invests in the human medicine, biotechnology, medical technology, and diagnostics sectors and related areas. The company holds and manages an international portfolio of companies.
24GF Score

Get the complete analysis for HBMBF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$287.35
Price